首页> 外文OA文献 >Maximising value from a United Kingdom Biomedical Research Centre: study protocol
【2h】

Maximising value from a United Kingdom Biomedical Research Centre: study protocol

机译:最大化英国生物医学研究中心的价值:研究方案

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Biomedical Research Centres (BRCs) are partnerships between healthcare organisations and universities in England. Their mission is to generate novel treatments, technologies, diagnostics and other interventions that increase the country’s international competitiveness, to rapidly translate these innovations into benefits for patients, and to improve efficiency and reduce waste in healthcare. As NIHR Oxford BRC (Oxford BRC) enters its third 5-year funding period, we seek to (1) apply the evidence base on how best to support the various partnerships in this large, multi-stakeholder research system and (2) research how these partnerships play out in a new, ambitious programme of translational research.Organisational case study, informed by the principles of action research. A cross-cutting theme, ‘Partnerships for Health, Wealth and Innovation’ has been established with multiple sub-themes (drug development, device development, business support and commercialisation, research methodology and statistics, health economics, bioethics, patient and public involvement and engagement, knowledge translation, and education and training) to support individual BRC research themes and generate cross-theme learning.The ‘Partnerships’ theme will support the BRC’s goals by facilitating six types of partnership (with patients and citizens, clinical services, industry, across the NIHR infrastructure, across academic disciplines, and with policymakers and payers) through a range of engagement platforms and activities. We will develop a longitudinal progress narrative centred around exemplar case studies, and apply theoretical models from innovation studies (Triple Helix), sociology of science (Mode 2 knowledge production) and business studies (Value Co-creation). Data sources will be the empirical research studies within individual BRC research themes (who will apply separately for NHS ethics approval), plus documentary analysis and interviews and ethnography with research stakeholders. This study has received ethics clearance through the University of Oxford Central University Research Ethics Committee.We anticipate that this work will add significant value to Oxford BRC. We predict accelerated knowledge translation; closer alignment of the innovation process with patient priorities and the principles of responsible, ethical research; reduction in research waste; new knowledge about the governance and activities of multi-stakeholder research partnerships and the contexts in which they operate; and capacity-building that reflects the future needs of a rapidly-evolving health research system.
机译:生物医学研究中心(BRC)是医疗机构与英格兰大学之间的合作伙伴关系。他们的任务是产生新颖的治疗方法,技术,诊断方法和其他干预措施,以提高该国的国际竞争力,将这些创新迅速转化为患者受益,并提高医疗效率并减少医疗浪费。随着NIHR牛津BRC(Oxford BRC)进入其第三个5年融资期,我们力求(1)在如何在这种大型,多利益相关方研究系统中最佳支持各种伙伴关系的基础上应用证据,以及(2)研究如何这些合作伙伴关系将在一项新的,雄心勃勃的翻译研究计划中发挥作用。组织案例研究以行动研究的原理为基础。跨领域的主题是“健康,财富和创新的伙伴关系”,其中包含多个子主题(药物开发,设备开发,业务支持和商业化,研究方法和统计,健康经济学,生物伦理学,患者和公众参与以及参与,知识翻译以及教育和培训),以支持BRC的各个研究主题并产生跨主题的学习.``伙伴关系''主题将通过促进六种类型的伙伴关系(与患者和公民,临床服务,行业,通过一系列参与平台和活动,跨NIHR基础设施,跨学科,与政策制定者和付款人进行交流。我们将围绕示例案例研究展开纵向的进展叙述,并应用创新研究(Triple Helix),科学社会学(模式2知识生产)和商业研究(价值共创)的理论模型。数据来源将是各个BRC研究主题下的经验研究(他们将分别申请NHS伦理学批准),以及文献分析以及与研究利益相关者的访谈和人种志。这项研究已通过牛津大学中央大学研究伦理委员会获得伦理审查。我们预计这项工作将为牛津BRC带来重大价值。我们预计知识会加速翻译;将创新过程与患者的优先重点以及负责任的伦理研究原则紧密结合起来;减少研究浪费;关于多方利益相关者研究伙伴关系的治理和活动及其运作背景的新知识;以及反映快速发展的卫生研究系统未来需求的能力建设。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号